Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The conclusion cannot be provided because the document content is not available.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Selenium therapy improved health in cystic fibrosis patients with fewer side effects at a lower dose.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Semaglutide may help some skin disorders but can also cause skin issues.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.